Skip to content
Vensana

Vensana

  • Our Team
  • Values
  • Our Entrepreneurs

Author: Justin Klein

Vensana in the News

Medtech investor duo seeks to ‘fill the gap’ in device sector private funding

Vensana in the News

New Minnesota-based fund has $225 million to invest in young med-tech companies

19

Novel FDA PMA & de novo 510k approvals

45

U.S. Commercial Product Launches

34

Level I Clinical Trials

26

Strategic Financings

28

Exits by IPO or M&A

VENSANA CAPITAL

CAPITAL PARTNERS FOR HEALTHCARE ENTREPRENEURS®

Ready to change healthcare together? Contact us to arrange for investments in development and commercial stage companies.

Get in Touch

Our Latest

See All News
Artelon, Inc. Secures $20M in Funding to Advance Surgical Treatment of Joint Instability
Relievant Medsystems Raises $50 Million to Advance the Treatment for Chronic Vertebrogenic Low Back Pain
Alleviant Medical Closes $75M in Financing; Receives FDA IDE Approval for Pivotal Clinical Trial
Resources
News LP Access
Contact
[email protected] 612.217.8680
Engage
Minneapolis
Vensana Capital 3601 W 76th Street Suite 20 Minneapolis, MN 55435
Washington, D.C.
Vensana Capital 101 Church Street Suite D Vienna, VA 22180

© 2022 Vensana Capital Management, LLC | Privacy | Terms & Conditions